Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chokroverty, S.
Right arrow Articles by Duvoisin, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chokroverty, S.
Right arrow Articles by Duvoisin, R. C.
NEUROLOGY 1987;37:608
© 1987 American Academy of Neurology

A physiologic and pharmacologic study in anticholinergic-responsive essential myoclonus

Sudhansu Chokroverty, MBBS, FRCP, Mahendra K. Manocha, MBBS and Roger C. Duvoisin, MD

Department of Neurology, UMDNJ-Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital, New Brunswick; and the Neurology Service, VA Medical Center, Lyons, NJ.

We report the physiologic and pharmacologic analysis in two women, aged 18 and 17 years, with essential myoclonus. Both responded to benztropine mesylate and had been functioning normally. The physiologic analysis suggested ballistic movement overflow and audiogenic stimulus-sensitive myoclonus. The pharmacologic study showed a direct and mutual antagonism of physostigmine and anticholinergic agent on myoclonus, implying cholinergic hyperactivity in the pathophysiology of myoclonus.

Address correspondence and reprint requests to Dr. Chokroverty, PO Box 308, Lyons, NJ 07939.

Received February 13, 1986. Accepted for publication in final form August 12, 1986.




This article has been cited by other articles:


Home page
J Child NeurolHome page
T. S. Edgar
Oral Pharmacotherapy of Childhood Movement Disorders
J Child Neurol, January 1, 2003; 18(1_suppl): S40 - S49.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by AAN Enterprises, Inc.